PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a pioneer in the development of innovative cellular therapies, has announced its participation in two major healthcare conferences in April. Steven Kelly, President and Chief Executive Officer of Carisma Therapeutics, will lead corporate presentations at both events, which will be held virtually.
The first presentation is scheduled for the Needham 23rd Annual Virtual Healthcare Conference on Wednesday, April 10, at 3:45 PM Eastern Time. The second appearance by the company will be at the Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit on Monday, April 29, at 2:00 PM Eastern Time.
These presentations mark significant opportunities for Carisma Therapeutics to showcase its latest advancements and initiatives in the realm of cellular therapies. The company, known for its pioneering work in the field, aims to engage with industry watchers, potential investors, and partners through these high-profile events.
Interested parties can access live webcasts of the presentations on Carisma Therapeutics’ Investor Events webpage. For those unable to attend the live sessions, replays will be made available and archived on the company’s website for a limited time following each event.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.